CD274 and soft tissue sarcoma: Toulmonde et al. [13] found that only 3 of 50 patients with soft tissue sarcoma showed any response to treatment with Pembrolizumab and Cyclophosphamide; six patients in total had a PD-L1-positive (≥1%) tumor.